Monte Rosa Therapeutics
GLUE
#6712
Rank
S$0.95 B
Marketcap
S$11.15
Share price
-3.03%
Change (1 day)
-39.98%
Change (1 year)

EPS for Monte Rosa Therapeutics (GLUE)

EPS in 2026 (TTM): S-$2.19

According to Monte Rosa Therapeutics's latest financial reports the company's current EPS (TTM) is S-$2.20. In 2025 the company made an earnings per share (EPS) of S-$1.00 an increase over its 2024 EPS that were of S-$1.33.

EPS history for Monte Rosa Therapeutics from 2022 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S-$2.19120.55%
2025S-$1.00-25.22%
2024S-$1.33-60.93%
2023S-$3.4115.28%
2022S-$2.95